HIF1A and colorectal carcinoma: Curcumol has been identified as a potent agent that promotes the degradation of HIF1α, effectively inhibiting the epithelial-mesenchymal transition (EMT) and consequently reducing the invasive and migratory capabilities of CRC cells.